Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
41.1M
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
7.03M
-
Shares change
-
+196K
-
Total reported value, excl. options
-
$16.5M
-
Value change
-
+$460K
-
Number of buys
-
4
-
Number of sells
-
-2
-
Price
-
$2.35
Significant Holders of Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB) as of Q2 2023
11 filings reported holding ANEB - Anebulo Pharmaceuticals, Inc. - Common Stock as of Q2 2023.
Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.03M shares
of 41.1M outstanding shares and own 17.13% of the company stock.
Largest 10 shareholders include 22NW, LP (5.07M shares), LVW Advisors, LLC (672K shares), Nantahala Capital Management, LLC (511K shares), MANGROVE PARTNERS (399K shares), Praetorian PR LLC (180K shares), Ikarian Capital, LLC (156K shares), BOOTHBAY FUND MANAGEMENT, LLC (17.3K shares), VANGUARD GROUP INC (16K shares), BlackRock Inc. (7.25K shares), and Tower Research Capital LLC (TRC) (6.1K shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.